Cargando…
A reappraisal of the mucoactive activity and clinical efficacy of bromhexine
Since its introduction to the market in 1963, bromhexine, an over-the-counter drug, has been investigated for its activity in animal models and in humans with diverse respiratory conditions. Bromhexine is a derivate of the Adhatoda vasica plant used in some countries for the treatment of various res...
Autores principales: | Zanasi, Alessandro, Mazzolini, Massimiliano, Kantar, Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359817/ https://www.ncbi.nlm.nih.gov/pubmed/28331610 http://dx.doi.org/10.1186/s40248-017-0088-1 |
Ejemplares similares
-
Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?
por: Scaglione, Francesco, et al.
Publicado: (2019) -
Efficacy of Pilocarpine and Bromhexine in Improving Radiotherapy-induced Xerostomia
por: Abbasi, Farid, et al.
Publicado: (2013) -
Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians
por: Yan, Xixin, et al.
Publicado: (2017) -
Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists
por: Volpi, Sonia, et al.
Publicado: (2022) -
Rational use of mucoactive medications to treat pediatric airway disease
por: Linssen, R.S.N., et al.
Publicado: (2020)